Abstract

BackgroundMesenchymal stromal cells (MSC) are increasingly investigated for their clinical utility in dogs. Fetal bovine serum (FBS) is a common culture supplement used for canine MSC expansion. However, FBS content is variable, its clinical use carries risk of an immune response, and its cost is increasing due to global demand. Platelet lysate (PL) has proven to be a suitable alternative to FBS for expansion of human MSC.Hypothesis and ObjectivesWe hypothesized that canine adipose tissue (AT) and bone marrow (BM) MSC could be isolated and expanded equally in PL and FBS at conventionally-used concentrations with differentiation of these MSC unaffected by choice of supplement. Our objectives were to evaluate the use of canine PL in comparison with FBS at four stages: 1) isolation, 2) proliferation, 3) spontaneous differentiation, and 4) directed differentiation.Results1) Medium with 10% PL was unable to isolate MSC. 2) MSC, initially isolated in FBS-supplemented media, followed a dose-dependent response with no significant difference between PL and FBS cultures at up to 20% (AT) or 30% (BM) enrichment. Beyond these respective peaks, proliferation fell in PL cultures only, while a continued dose-dependent proliferation response was noted in FBS cultures. 3) Further investigation indicated PL expansion culture was inducing spontaneous adipogenesis in concentrations as low as 10% and as early as 4 days in culture. 4) MSC isolated in FBS, but expanded in either FBS or PL, maintained ability to undergo directed adipogenesis and osteogenesis, but not chondrogenesis.Conclusions/SignificanceCanine PL did not support establishment of MSC colonies from AT and BM, nor expansion of MSC, which appear to undergo spontaneous adipogenesis in response to PL exposure. In vivo studies are warranted to determine if concurrent use of MSC with any platelet-derived products such as platelet-rich plasma are associated with synergistic, neutral or antagonistic effects.

Highlights

  • Over the last 15 years, increasing efforts have been put toward the innovation and optimization of stem cell-based therapies for conditions where currently there are poor or no treatments available

  • Proliferation fell in Platelet lysate (PL) cultures only, while a continued dose-dependent proliferation response was noted in fetal bovine serum (FBS) cultures

  • Our results show PL performing inadequately in the key areas of Mesenchymal stromal cells (MSC) isolation and long-term expansion

Read more

Summary

Introduction

Over the last 15 years, increasing efforts have been put toward the innovation and optimization of stem cell-based therapies for conditions where currently there are poor or no treatments available. While adipose tissue is reported to yield a 500-fold increase in MSC per millilitre when compared to marrow, ex vivo expansion is still required before the amount and concentration necessary for clinical application is acquired [8,9]. Whether in human or canine research, a lack of standardized protocols is a key barrier to clinically safe and reliable MSC-based therapies [10]. One of the known causes of variability in current protocols is the inclusion of fetal bovine serum (FBS) in the culture medium used. Fetal bovine serum (FBS) is a common culture supplement used for canine MSC expansion. FBS content is variable, its clinical use carries risk of an immune response, and its cost is increasing due to global demand. Platelet lysate (PL) has proven to be a suitable alternative to FBS for expansion of human MSC.

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call